dual gip glp 1 receptor agonists GLP-1/GIP Agonist | Tirzepatide | Obesity & T2DM Mx | Harrison's Update(22nd Ed.) PDB-101: Molecule of the Month:
Description
National Post reports generic semaglutide products could reach Canadian pharmacy shelves by summer 2026 as Health Canada reviews nine applications.
Methods This is a cohort study combining several population-wide databases and covering a Spanish population of five million inhabitants, including all adults with obesity who initiated treatment with either GLP-1RA or SGLT-2i for type 2 diabetes from 2015 to 2021
Leave-one-out sensitivity analyses confirmed the direction and magnitude of the AUD finding but highlighted the limited evidence base for hospitalization
Mercedez Hernandez walks through what patients should consider when weighing their options.
Experts explain why hunger, food noise and other health changes return after stopping weight loss drugs and how to hold onto your progress.
Quality Assurance & Verification
